Global Generative AI in Life Sciences Market 2025-2029

Generative AI In Life Sciences Market 2025-2029

The generative ai in life sciences market is forecasted to grow by USD 1055.8 mn during 2024-2029, accelerating at a CAGR of 20.3% during the forecast period. The report on the generative ai in life sciences market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by imperative to enhance research and development efficiency, proliferation of high volume, multimodal biological data, and advancements in foundational ai and computing infrastructure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's generative ai in life sciences market is segmented as below:

By Application

• Drug discovery
• Personalized medicine
• Clinical trials

By Technology

• Novel molecule generation
• Protein sequence design
• Synthetic gene design

By Deployment

• Cloud-based
• On-premises
• Hybrid

By Geographical Landscape

• North America
• Europe
• APAC
• Middle East and Africa
• South America

This study identifies the emergence of integrated, closed-loop discovery platforms as one of the prime reasons driving the generative ai in life sciences market growth during the next few years. Also, development of large foundational models for biology and expansion beyond discovery into clinical and regulatory applications will lead to sizable demand in the market.

The report on the generative ai in life sciences market covers the following areas:

• Generative AI In Life Sciences Market sizing
• Generative AI In Life Sciences Market forecast
• Generative AI In Life Sciences Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generative ai in life sciences market vendors that include AiCure, Atomwise Inc., BenevolentAI, Boehringer Ingelheim International GmbH, Clarivate PLC, Evogene Ltd., Fujitsu Ltd., Google LLC, Insilico Medicine, International Business Machines Corp., Microsoft Corp., NVIDIA Corp., Owkin Inc., PathAI Inc., Recursion Pharmaceuticals Inc., Sanofi SA, Schrodinger Inc., SOPHiA GENETICS, and Tencent Holdings Ltd.. Also, the generative ai in life sciences market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth. Show more